secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2026-06-16T20:00:25+00:00
Accession:  0001493152-26-028878
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lixte Biotechnology to acquire NOMAD Transportable Power Systems, pivoting to energy storage
--------------------------------------------------------------------------------

- Consideration: up to 50,500 Series D Convertible Preferred shares ($1,000/sh, convertible at $1.00) plus up to 3M common shares.
- Closing condition: Lixte must hold at least $16.5M unrestricted cash; proxies for 33% of common stock to approve conversion.
- NOMAD revenue grew ~175% YoY in 2025, projected ~135% YoY growth in 2026; ~75% of sales inbound and >30 active opportunities.
- Company to be renamed NOMAD Power Solutions; John Travaglini named CEO of merger sub and board member.
- NOMAD first-to-market with mobile, utility-grade 1 MW BESS; UL 9540 validated, bypassing permanent BESS permitting delays.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315226028878/0001493152-26-028878-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315226028878/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-028878

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer